Allergy Therapeutics PLC VLP Peanut - a Next Generation Peanut Allergy Immunotherapy Call Transcript
Good day ladies and gentlemen. Welcome to Allergy Therapeutics KOL webinar on VLP Peanut, a new generation peanut allergy immunotherapy. (Operator Instructions)
I will now hand over to the CEO of Allergy Therapeutics Manuel Llobet to open the presentation. Please go ahead.
Hello, everybody. Good afternoon. Thank you very much for attending our key opinion leaders event on peanut allergy. I hope you find it interesting and we are very pleased to have you with us today.
When we started our peanut vaccine back in 2016, we saw an opportunity to make a big difference in the food allergy area. Though there were already 2 product candidates in development, there was still a big unmet need even if these candidates were going to succeed. Both were long-term treatments with predictable low compliance and most importantly would not have a disease-modifying effect. We were narrowing the same type of opportunity we saw in the allergic rhinitis field where we introduced the Pollinex
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
